The short answer
Cardiorenal syndrome (CRS) describes a group of conditions in which problems with the heart and kidneys affect each other. Heart failure can worsen kidney function, while chronic kidney disease (CKD) can increase the strain on the heart and make heart failure more difficult to manage.
This is not simply a matter of “poor blood flow to the kidneys.” Fluid congestion, blood pressure changes, hormonal activation, inflammation, medications, and underlying diseases such as diabetes and vascular disease can all contribute. (professional.heart.org)
The important point is that a change in kidney function during heart failure does not automatically mean permanent kidney damage. Kidney function has to be interpreted alongside fluid status, blood pressure, medications, urine findings, previous results, and the overall clinical situation. (professional.heart.org)
What is cardiorenal syndrome?
Your heart and kidneys perform different jobs, but they constantly depend on each other.
- The heart pumps blood throughout the body.
- The kidneys filter blood, remove waste, regulate fluid and electrolytes, and help control blood pressure.
When the heart cannot pump or fill normally, the kidneys may receive altered blood flow or become congested. The kidneys then respond in ways that can cause the body to retain more sodium and water, increasing the workload on the heart.
The relationship can also run in the opposite direction. Long-standing CKD can contribute to high blood pressure, fluid retention, anemia, vascular disease, and other changes that increase cardiovascular stress.
That is why cardiorenal syndrome is better understood as a two-way heart–kidney interaction, rather than a single disease.
Why can heart failure affect the kidneys?
It is tempting to think:
Heart failure → less blood reaches the kidneys → kidney failure.
That explanation is incomplete.
One important problem is congestion. When heart failure causes pressure to build up in the veins, that pressure can be transmitted back toward the kidneys. The kidneys may become less effective at filtering and handling sodium and water.
At the same time, the body activates systems such as the renin-angiotensin-aldosterone system and sympathetic nervous system. These responses are intended to maintain circulation, but persistent activation can promote fluid retention and increase vascular stress.
Therefore, someone with heart failure can experience a worsening creatinine or eGFR because of hemodynamic changes and congestion without necessarily developing new structural kidney disease. (professional.heart.org)
How can CKD affect the heart?
The reverse pathway is equally important.
As CKD progresses, several factors can place additional stress on the cardiovascular system:
- High blood pressure
- Sodium and fluid retention
- Anemia
- Abnormal mineral and bone metabolism
- Increased cardiovascular risk associated with CKD
- Diabetes and other shared underlying diseases
- Changes in blood vessels and cardiac structure
This does not mean that CKD inevitably causes heart failure. Rather, CKD and heart disease frequently coexist and can worsen each other’s clinical impact. (KDIGO)
The five types of cardiorenal syndrome
Clinicians traditionally divide CRS into five types:
- Type 1: Acute heart problems cause acute kidney dysfunction.
Example: sudden worsening of heart failure followed by an acute rise in creatinine. - Type 2: Chronic heart disease contributes to progressive kidney dysfunction.
- Type 3: Acute kidney injury contributes to acute heart problems, such as fluid overload or cardiovascular instability.
- Type 4: Chronic kidney disease contributes to chronic cardiovascular disease or heart failure.
- Type 5: A systemic illness affects both organs at the same time.
This classification is useful for understanding the direction and timing of the problem, but real patients do not always fit neatly into one category.
Does a rising creatinine during heart failure mean kidney damage?
Not necessarily.
Creatinine is a useful marker of kidney function, but it is not a direct measurement of structural kidney injury.
During treatment for congestive heart failure, creatinine can sometimes rise as fluid is removed and circulation changes. A clinician therefore looks at the whole picture, including:
- Previous and current creatinine/eGFR
- How quickly the change occurred
- Fluid status and congestion
- Blood pressure
- Urine output
- Urinalysis and urine protein when appropriate
- Electrolytes
- Medication changes
- Whether the patient is improving clinically
The American Heart Association notes that kidney dysfunction in advanced heart failure can fluctuate because of hemodynamic and neurohormonal factors, and that assessment may require more than eGFR alone. (professional.heart.org)
So:
A creatinine increase deserves attention, but it does not automatically prove permanent kidney injury.
Why treatment can be complicated
Treating one organ can sometimes affect the other.
For example, diuretics are commonly used to remove excess fluid in heart failure. They can be essential when congestion is present, but excessive fluid removal can contribute to low blood pressure, dehydration, or worsening kidney function in some circumstances.
Similarly, medications that affect the renin-angiotensin system can change creatinine and potassium while providing important cardiovascular and kidney benefits in appropriate patients.
This is why medications should not be labeled simply as “kidney-damaging.”
A medication-related change in creatinine must be interpreted in context. Do not stop heart-failure or kidney-protective medication on your own because a creatinine result changes.
Where do SGLT2 inhibitors fit?
SGLT2 inhibitors have become an important part of the connection between heart and kidney care.
Although originally developed as diabetes medications, drugs in this class have demonstrated cardiovascular and kidney benefits in appropriate patients, including some people with heart failure and CKD.
KDIGO recommends SGLT2 inhibitor therapy for certain people with CKD, including people with CKD and heart failure, subject to the relevant clinical criteria. (KDIGO)
They can also cause a small early fall in eGFR after starting treatment. This is not automatically evidence of kidney damage; the change is often reversible and kidney function can stabilize afterward. (KDIGO)
Whether an SGLT2 inhibitor is appropriate depends on the person’s kidney function, heart condition, diabetes status, medications, volume status, and other factors.
What tests may be useful?
There is no single test that diagnoses every form of cardiorenal syndrome.
Depending on the situation, clinicians may assess:
- Creatinine and eGFR — estimates kidney filtration
- Electrolytes, especially potassium and sodium
- Urine albumin/protein — provides information about kidney damage
- Blood pressure
- Weight and fluid status
- Heart imaging such as an echocardiogram
- Other cardiac or kidney biomarkers when clinically appropriate
- Kidney imaging when there is a specific reason to investigate structural disease
A trend is usually more informative than one isolated kidney-function measurement.
For example:
Previous eGFR → current eGFR → size of change → time interval → symptoms and clinical context
is much more useful than looking at the current eGFR alone.
What can someone with heart failure and CKD do?
Management is usually about protecting both organs, rather than treating them separately.
Useful steps include:
- Keep blood pressure under appropriate control.
- Take prescribed heart and kidney medications as directed.
- Have kidney function and electrolytes monitored when medications are started or changed.
- Avoid unnecessary NSAID use unless a clinician specifically advises otherwise.
- Follow individualized sodium and fluid recommendations.
- Manage diabetes when present.
- Track meaningful changes in weight, swelling, blood pressure, and symptoms when advised.
- Keep cardiology and kidney-care clinicians informed about medication changes and new laboratory results.
Dietary restrictions should also be individualized. Someone with early CKD does not automatically need the same potassium, phosphorus, protein, or fluid restrictions as someone with advanced CKD or dialysis-dependent kidney failure.
When should medical attention be urgent?
Seek urgent medical evaluation for symptoms such as:
- Severe or rapidly worsening shortness of breath
- Chest pain
- Fainting or severe weakness
- New confusion
- Very little or no urine
- Rapidly worsening swelling accompanied by breathing difficulty
- Severe vomiting or dehydration
A severely abnormal potassium or other critical laboratory result may also require urgent assessment, even when the person does not feel particularly ill.
Bottom line
Cardiorenal syndrome is a two-way relationship between heart and kidney dysfunction. Heart failure can impair kidney function through congestion and hemodynamic changes, while CKD can increase cardiovascular stress through fluid retention, high blood pressure, anemia, vascular disease, and other mechanisms.
The most important misconception to avoid is that every decline in eGFR or rise in creatinine during heart failure represents permanent kidney damage.
Good cardiorenal care means looking at kidney trends, fluid status, blood pressure, urine findings, medications, heart function, and the patient’s overall condition together. Modern treatments—including appropriately selected heart-failure therapies and SGLT2 inhibitors—can benefit both sides of the heart–kidney relationship. (KDIGO)
For someone living with both conditions, the goal is not simply to protect the heart or the kidneys. It is to manage the factors that affect both organs at the same time.